TG
Therapeutic Areas
Omnix Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OMN51 | Multidrug‑resistant Gram‑negative bacterial infections (e.g., Pseudomonas aeruginosa) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| OMN51 | Multidrug‑resistant Gram‑negative bacterial infections (e.g., Pseudomonas aeruginosa) | Preclinical |